Loading...
Market
What will Eli Lilly's Q4 2024 revenue be?
3
Resolution / Starting Odds
Below $8 billion • 25%
$8 billion to $10 billion • 25%
$10 billion to $12 billion • 25%
Above $12 billion • 25%
Eli Lilly's Q4 2024 financial report
Story
Eli Lilly Cuts Zepbound Price by 50%, Impacting Hims Stock and Earning Biden's Praise
Aug 27, 2024, 03:28 PM
Eli Lilly has announced a significant price reduction for its weight-loss drug Zepbound, now offering single-dose vials at a 50% discount. This move aims to expand access to the drug, particularly for patients without insurance coverage. The discounted vials are available through Lilly's direct-to-consumer platform, LillyDirect, with prices set at $399 for a four-week supply of the 2.5 mg dose and $549 for the 5 mg dose. This initiative is part of Eli Lilly's strategy to address supply shortages and increase the availability of Zepbound amid rising demand. The price cut poses a challenge to telehealth companies that offer compounded versions of the medication. In response to the announcement, shares of Hims & Hers Health fell, reflecting the competitive impact of Lilly's strategy. Additionally, President Biden praised the price reduction as a positive step towards making medications more affordable.
View original story
Similar markets
Below $45 billion • 25%
$45 billion to $45.5 billion • 25%
$45.5 billion to $46 billion • 25%
Above $46 billion • 25%
$45.4 billion to $46.6 billion • 25%
Less than $45.4 billion • 25%
More than $46.6 billion • 25%
Between $46.0 billion and $46.6 billion • 25%
Below $1.00 • 25%
$1.00 to $1.25 • 25%
$1.26 to $1.50 • 25%
Above $1.50 • 25%
Below 10% • 25%
10% to 15% • 25%
15% to 20% • 25%
Above 20% • 25%
Exceeds expectations • 25%
Meets expectations • 25%
Slightly below expectations • 25%
Significantly below expectations • 25%
10-15% • 25%
0-5% • 25%
5-10% • 25%
15% or more • 25%
Increase by 0-10% • 25%
Increase by more than 10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Less than 5% • 25%
5% to 10% • 25%
10% to 15% • 25%
More than 15% • 25%
Less than $500 • 25%
$500 to $600 • 25%
$600 to $700 • 25%
More than $700 • 25%